LINDA ARNOLD: Open Payments
NPI 1194710293 · GRAY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,786 in 94 payments from 20 companies in 2025. Trend: 2023 $1,283 · 2024 $1,824 · 2025 $1,786
Food & beverage: $1,786
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $287 |
| PFIZER INC. | 15 | $279 |
| Novo Nordisk Inc | 11 | $192 |
| AstraZeneca Pharmaceuticals LP | 8 | $184 |
| Lilly USA, LLC | 6 | $105 |
| Corcept Therapeutics | 5 | $93 |
| GlaxoSmithKline, LLC. | 5 | $87 |
| Amgen Inc. | 5 | $86 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
Products named: VRAYLAR, NURTEC ODT, REXULTI, FARXIGA, MOUNJARO, Wegovy, Korlym, OTEZLA.
Industry payments across GA — which companies pay providers there.
